The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
Shabbir Safdar, the executive director of the Partnership for Safe Medicines, an advocacy group that tracks counterfeit drugs, said fake GLP-1 medications are “the No. 1 fraud issue” that ...
For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that ...
Kentucky leads the nation with 21 prescriptions per 1,000 residents, reflecting its 36.5% obesity rate and robust healthcare access.
Digital technologies loom large on the list—from the growing impact of artificial intelligence to the need for tech-enabled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback